Abstract
Background Coronary artery bypass graft (CABG) surgery is the most widely performed adult cardiac surgery in the US. Transesophageal echocardiography (TEE) is an ultrasound-based cardiac imaging modality used in CABG surgery for hemodynamic monitoring and management of complications related to cardiopulmonary bypass. However, there are no comparative effectiveness studies (randomized or non-randomized) that have investigated the relationship between TEE monitoring and clinical outcomes among patients undergoing CABG surgery. Because of this lack of evidence, recommendations for TEE in CABG surgery remain indeterminate (Class II). We aim to compare the clinical outcomes of patients undergoing CABG surgery with vs without TEE monitoring. This protocol will detail how we plan to investigate the hypothesis that TEE monitoring in CABG surgery will be associated with improved clinical outcomes.
Methods and Analysis This investigation will be an observational retrospective, comparative effectiveness, cohort study using Centers for Medicare and Medicaid Services (CMS) claims data from January 1, 2013 to October 15, 2015. The aim is to determine if TEE monitoring during CABG surgery is associated with improved 30-day survival, lower incidence of stroke, shorter length of hospitalization, and incidence of esophageal perforation. To alleviate the potential bias from unmeasured confounding, we propose leveraging hospitals’ (or surgeons’) preference for TEE in CABG surgery as an instrumental variable (IV). We will combine this IV technique with statistical-matching-based methods by pairing hospitals (or surgeons) with similar observed confounding variables but considerably different preference for TEE monitoring in CABG surgery. Our research design is meant to emulate a cluster-randomized encouragement experiment. The following a priori protocol will detail how we plan to execute this analysis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was not supported by any external funding agencies
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This retrospective observational cohort study was reviewed and approved as exempt by the University of Pennsylvania IRB.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used for this study are available for purchase from the Centers for Medicare and Medicaid Services (CMS). This work was conducted in accordance with a Data Use Agreement (DUA) with CMS. We are not permitted to share the data directly.
